NanoViricides, Inc.NNVCNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P21
Within normal range
vs 5Y Ago
-1.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-12.63%
20244.78%
2023-10.23%
20227.21%
2021-9.35%
20207.66%
20197.14%
20182.87%
2017-8.37%
2016-25.43%